C3A产品图

C3A

收藏
  • 询价
  • 2026年09月29日
    avatar
    15 年金牌会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 相关疾病:

      肝癌

    • 器官来源:

      肝

    • ATCC Number:

      CRL-10741™

    • 年限:

      15 years adolescent

    • 生长状态:

      贴壁生长

    • 库存:

      大量

    • 细胞形态:

      上皮样

    • 运输方式:

      冻存运输

    • 物种来源:

      人

    • 是否是肿瘤细胞:

      1

    Designations: C3A [HepG2/C3A, derivative of Hep G2 (ATCC HB-8065)]
    Depositors:  Baylor College of Medicine
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: liver
    Disease: hepatocellular carcinoma
    Cellular Products: alpha-fetoprotein (alpha fetoprotein); albumin; alpha2 macroglobulin (alpha-2-macroglobulin); alpha1 antitrypsin (alpha-1-antitrypsin); transferrin; alpha1 antichymotrypsin; (alpha-1-antichymotrypsin); haptoglobin; ceruloplasmin; plasminogen;
    complement (C4); C3 activator; fibrinogen; alpha1 acid glycoprotein (alpha-1 acid glycoprotein); alpha2 HS glycoprotein (alpha-2-HS-glycoprotein); beta lipoprotein (beta-lipoprotein); retinol binding protein (retinol-binding protein)
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Applications: transfection host
    Tumorigenic: No
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 10,11
    D13S317: 9,13
    D16S539: 12,13
    D5S818: 11,13
    D7S820: 10
    THO1: 9
    TPOX: 8,9
    vWA: 17
    Age: 15 years adolescent
    Gender: male
    Ethnicity: Caucasian
    Comments: C3A is clonal derivative of Hep G2 that was selected for strong contact inhibition of growth, high albumin production, high production of alpha fetoprotein (AFP) and ability to grow in glucose deficient medium.
    As the cells become confluent, there is a marked reduction in AFP secretion and an increase in albumin secretion.
    Gluconeogenesis activity is strongly oxgen dependent.
    The cells have nitrogen metabolizing activity comparable to perfused rat livers.
    There is no evidence of a Hepatitis B virus genome in this cell line.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. Add appropriate aliquots of the cell suspension to new culture vessels.
    6. Incubate cultures at 37�C.

        Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
        Medium Renewal: Twice per week
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2003
    recommended serum:ATCC 30-2020
    parental cell line:ATCC HB-8065
    References: 22052: Kelly JH. Permanent human hepatocyte cell line and its use in a liver assist device (LAD). US Patent 5,290,684 dated Mar 1 1994

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 小鼠补体C3a(C3a)ELISA试剂盒 说明书

        上海西唐生物科技有限公司   021-55229872,  65333639   www.westang.com 小鼠补体C3a (C3a)ELISA 试剂盒   ( 用于血清、血浆、细胞培养上清液和尿液、唾液生物体液内 )   原理 本实验采用双抗体夹心  ABC-ELISA 法。用抗小鼠   C3a   单抗包被于酶标板上,标准品和样品中的   C3a与单抗结合,加入生物素化的抗小鼠 C3a

    • 小鼠补体3a(C3a)酶联免疫分析(ELISA)

      小鼠 补体3a(C3a) 酶联免疫 分析( ELISA ) 试剂 盒使用说明书 本试剂仅供研究使用          目的:本试剂盒用于测定小鼠血清,血浆及相关液体样本中 补体3a(C3a) 含量。 实验原理 :     本试剂盒应用双抗体夹心法测定 标本 中 小鼠 补体3a ( C3a ) 水平。用纯化的 小鼠  C3a 抗体包被微孔板,制成固相抗体,往包被单抗的微孔中依次加入 补体3a ( C3a ), 再与HRP 标记的 C3a 抗体

    • 人补体C3a(C3a)ELISA试剂盒 说明书

      人补体C3a (C3a)ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 C3a 单抗包被于酶标板上,标准品和样品中的 C3a与单抗结合,加入生物素化的抗人 C3a ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1620
    博辉生物科技(广州)有限公司
    2025年10月28日询价
    ¥800
    上海沪震实业有限公司
    2025年07月16日询价
    ¥800
    上海康朗生物科技有限公司
    2025年07月11日询价
    ¥680
    上海联迈生物工程有限公司
    2026年09月17日询价
    询价
    上海复祥生物科技有限公司
    2026年09月15日询价
    C3A
    询价